| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $47.6M | +8.4% |
| SG&A Expense | $26.9M | -9.6% |
| Operating Income | -$80.7M | -0.7% |
| Interest Expense | $25K | -87.5% |
| Pre-tax Income | -$71.1M | -1478.1% |
| Net Income | -$71.1M | -1478.1% |
| EPS (Basic) | -$0.49 | -1325.0% |
| EPS (Diluted) | -$0.49 | -1325.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.8M | -54.5% |
| Short-term Investments | $45.4M | — |
| Current Assets | $101.0M | -16.2% |
| Total Assets | $119.9M | -14.6% |
| Current Liabilities | $7.3M | -13.3% |
| Long-term Debt | $2.0M | — |
| Total Liabilities | $21.9M | -25.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.3M | -1.8% |
| Capital Expenditures | $1.7M | -68.8% |
| Investing Cash Flow | -$45.8M | -755.4% |
| Financing Cash Flow | $44.7M | +388.8% |
| Free Cash Flow | -$64.0M | +3.9% |
| Stockholders' Equity |
| $98.0M |
| -11.8% |